Rapid Dose Therapeutics and Aavishkar Granted Monolayer QuickStrip(TM) Nicotine Patent, Advancing RDT's Global Commercialization Strategy
Burlington, Ontario--(Newsfile Corp. - August 20, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company specializing in innovative oral thin film drug delivery technology, today announced that, together with its development partner Aavishkar Oral Strips Pvt. Ltd. ("Aavishkar"), have been granted a second key patent covering its QuickStrip™ nicotine oral-film technology.The Patent Office, Government of India has granted Patent...
Free plan · Plus CA$29 or Pro CA$99/month


